trending Market Intelligence /marketintelligence/en/news-insights/trending/KMmfhztzQbkIpoEa85AILQ2 content esgSubNav
In This List

Integra increases credit facility to fund acquisition of J&J's neurosurgery biz

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Integra increases credit facility to fund acquisition of J&J's neurosurgery biz

Integra LifeSciences Holdings Corp. increased its credit facility to finance the acquisition of Johnson & Johnson's Codman Neurosurgery business.

The medical technology company will be borrowing an extra $700 million from its bank group led by Bank of America NA, expanding the credit facility to $2.2 billion from $1.5 billion.

The $700 million term loan will be available in a single drawing on a delayed basis, upon closing of the acquisition.

The acquisition is expected to close in the fourth quarter, Integra CFO Glenn Coleman said in the news release.

The credit facility, comprising the expanded term loan of $1.2 billion and revolving credit of $1 billion, matures Dec. 7, 2021.